Article ; Online: Role of Interleukin-6 in Lung Complications in Patients With COVID-19: Therapeutic Implications.
2020 Volume 34, Issue 3 Suppl, Page(s) 1589–1592
Abstract: COVID-19 is viral respiratory infection with frequently fatal lung complications in the elderly or ... signaling pathway can attenuate such a cytokine storm and can be beneficial for patients with COVID-19 in danger ... related to an increased level of interleukin-6 (IL6). Therapeutic targeting of the interleukin-6 ...
Abstract | COVID-19 is viral respiratory infection with frequently fatal lung complications in the elderly or in people with serious comorbidities. Lung destruction appears to be associated with a cytokine storm related to an increased level of interleukin-6 (IL6). Therapeutic targeting of the interleukin-6 signaling pathway can attenuate such a cytokine storm and can be beneficial for patients with COVID-19 in danger of pulmonary failure. This article demonstrates the importance of IL6 in progression of disease and the possibility of inhibition of IL6 signaling in COVID-19 therapy. |
---|---|
MeSH term(s) | Anti-Inflammatory Agents/therapeutic use ; Antibodies, Monoclonal/therapeutic use ; Antibodies, Monoclonal, Humanized/therapeutic use ; Antiviral Agents/therapeutic use ; COVID-19 ; Clinical Trials as Topic ; Coronavirus Infections/complications ; Coronavirus Infections/drug therapy ; Coronavirus Infections/immunology ; Coronavirus Infections/physiopathology ; Cytokine Receptor gp130/antagonists & inhibitors ; Cytokine Receptor gp130/physiology ; Cytokine Release Syndrome/drug therapy ; Cytokine Release Syndrome/etiology ; Cytokine Release Syndrome/immunology ; Cytokine Release Syndrome/physiopathology ; Humans ; Immunotherapy ; Indoles/therapeutic use ; Interleukin-6/antagonists & inhibitors ; Interleukin-6/physiology ; Lung/pathology ; Pandemics ; Pneumonia, Viral/complications ; Pneumonia, Viral/drug therapy ; Pneumonia, Viral/immunology ; Pneumonia, Viral/physiopathology ; Receptors, Interleukin-6/antagonists & inhibitors ; Receptors, Interleukin-6/physiology ; Receptors, Virus/drug effects ; Signal Transduction |
Chemical Substances | Anti-Inflammatory Agents ; Antibodies, Monoclonal ; Antibodies, Monoclonal, Humanized ; Antiviral Agents ; IL6 protein, human ; Indoles ; Interleukin-6 ; Receptors, Interleukin-6 ; Receptors, Virus ; Cytokine Receptor gp130 (133483-10-0) ; bazedoxifene (Q16TT9C5BK) |
Keywords | covid19 |
Language | English |
Publishing date | 2020-06-05 |
Publishing country | Greece |
Document type | Journal Article ; Review |
ZDB-ID | 807031-3 |
ISSN | 1791-7549 ; 0258-851X |
ISSN (online) | 1791-7549 |
ISSN | 0258-851X |
DOI | 10.21873/invivo.11947 |
Database | MEDical Literature Analysis and Retrieval System OnLINE |
More links
Kategorien
In stock of ZB MED Cologne/Königswinter
Zs.A 2288: Show issues | Location: Je nach Verfügbarkeit (siehe Angabe bei Bestand) bis Jg. 1994: Bestellungen von Artikeln über das Online-Bestellformular Jg. 1995 - 2021: Lesesall (2.OG) ab Jg. 2022: Lesesaal (EG) |
Order via subito
This service is chargeable due to the Delivery terms set by subito. Orders including an article and supplementary material will be classified as separate orders. In these cases, fees will be demanded for each order.